breakthrough research
Genetics Plays A Role In COVID-19 Patients
PALFIR Genetics has successfully completed its phase 1 research into the new Coronavirus causing COVID-19 and we were able to discover that genetics plays a role as to why some individuals experience fewer to no symptoms to the COVID-19 compared to others who have much more serious symptoms and some of those individuals with these severe symptoms even face death.
During our first initial research we have found that the human leukocyte antigen (HLA) system Could play a role in peoples symptoms when they are infected with COVID-19. We have found that individuals with a specific human leukocyte antigen (HLA) allele had a higher chance of developing severe symptoms and we were also successful in our research to find another key HLA allele that showed this specific HLA allele played a role in individuals experiencing fewer or no symptoms to the COVID-19.
The results of this study is important as we could test Hospital staff for these HLA alleles and determine who is more at risk of showing much more serious symptoms and/or even death to this Coronavirus and to try to limited the exposure of those individuals to COVID-19 and try to staff the Hospitals with individuals who could be less affected by this virus.
We have moved to the second phase of our research. If you would like to participate in this study, please go to the "What We're Working On" page or to simply Click Here.
PALFIR Genetics has successfully completed its phase 1 research into the new Coronavirus causing COVID-19 and we were able to discover that genetics plays a role as to why some individuals experience fewer to no symptoms to the COVID-19 compared to others who have much more serious symptoms and some of those individuals with these severe symptoms even face death.
During our first initial research we have found that the human leukocyte antigen (HLA) system Could play a role in peoples symptoms when they are infected with COVID-19. We have found that individuals with a specific human leukocyte antigen (HLA) allele had a higher chance of developing severe symptoms and we were also successful in our research to find another key HLA allele that showed this specific HLA allele played a role in individuals experiencing fewer or no symptoms to the COVID-19.
The results of this study is important as we could test Hospital staff for these HLA alleles and determine who is more at risk of showing much more serious symptoms and/or even death to this Coronavirus and to try to limited the exposure of those individuals to COVID-19 and try to staff the Hospitals with individuals who could be less affected by this virus.
We have moved to the second phase of our research. If you would like to participate in this study, please go to the "What We're Working On" page or to simply Click Here.
